Zydus Lifesciences Ltd.

Cadila Healthcare has reported results for fourth quarter and year ended March 31, 2014

The company has reported 1.84% fall in its net profit of Rs 216.68 crore for the quarter ended March 31, 2014 as compared to Rs 220.74 crore for the same quarter in the previous year. However, total income of the company increased by 11.83% at Rs 1121.89 crore for quarter under review as compared to Rs 1003.24 crore for the quarter ended March 31, 2013.

On consolidated basis, the company has reported 8.74% fall in its net profit / (loss) after taxes, minority interest and share of profit / (loss) of associates at Rs 239.19 crore for the quarter ended March 31, 2014 as compared to Rs 262.11 crore for the same quarter in the previous year. However, total income of the company has increased by 22.30% at Rs 1981.63 crore for quarter under review as compared to Rs 1620.33 crore for the quarter ended March 31, 2013.

For the year ended March 31, 2014, the company has posted a rise of 81.24% in its net profit after taxes at Rs 903.59 crore as compared to Rs 498.55 crore for the same period in the previous year.  Total income of company improved by 21.51% at Rs 4350.70 crore for year under review as compared to Rs 3580.37 crore for the period ended March 31, 2013.

For the year ended March 31, 2014, on the consolidated basis, the company has posted a rise of 22.97% in its net profit after taxes & Minority interest at Rs 803.59 crore as compared to Rs 653.46 crore for the same period in the previous year. Total income of company has increased by 13.76% at Rs 7274.70 crore for year under review as compared to Rs 6394.78 crore in the previous fiscal.